Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Pharmaquest Corp. — Predicate Candidate Screening
14 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
39 daysmedian FDA review time
105 days90th percentile
14clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K945519 | FACE (FLUOROPHORE-ASSISTED-CARBOHYDRATE-ELECTROPHORESIS) URI | Pharmaquest Corp. | 1995-11-03 | 359 | 0 |
| K833880 | TELEPHONIC RECEIVER R-10 EEG | Pharmaquest Corp. | 1983-11-29 | 13 | 0 |
| K833236 | TELEPHONE TRANSMITTER T-10 EEG | Pharmaquest Corp. | 1983-11-29 | 105 | 0 |
| K830705 | MINI LANCET-BLOOD LANCET | Pharmaquest Corp. | 1983-04-08 | 32 | 0 |
| K822976 | HYPOCOUNT A | Pharmaquest Corp. | 1982-11-16 | 39 | 0 |
| K822486 | HOME BLOOD GLUCOSE MONITOR | Pharmaquest Corp. | 1982-11-05 | 80 | 0 |
| K820248 | RODDER VOLUME VENTILATOR | Pharmaquest Corp. | 1982-04-16 | 77 | 0 |
| K812849 | PTT-200 TELEPHONIC PULMONARY TRANSMITT | Pharmaquest Corp. | 1981-12-03 | 55 | 0 |
| K812850 | PTT-200 PULMONARY RECEIVER/MICROPROCES | Pharmaquest Corp. | 1981-12-03 | 55 | 0 |
| K813010 | EEG TELEPHONE TRANSMITTER, MODEL #T-7 | Pharmaquest Corp. | 1981-11-16 | 20 | 0 |
| K812683 | NEONATE FLEXFLOAT | Pharmaquest Corp. | 1981-10-13 | 21 | 0 |
| K812682 | FLEXFLOAT HEATER | Pharmaquest Corp. | 1981-10-08 | 16 | 0 |
| K812681 | ADULT FLEX FLOAT W/HEATER | Pharmaquest Corp. | 1981-10-08 | 16 | 0 |
| K812684 | ADULT FLEXFLOAT | Pharmaquest Corp. | 1981-10-08 | 16 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda